FindTrial
Sign In

Disease Burden of Eosinophilic Granulomatosis with Polyangiitis in China

Disease Burden of Eosinophilic Granulomatosis with Polyangiitis in China

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300072653
Enrollment
Unknown
Registered
2023-06-20
Start date
2022-03-07
Completion date
Unknown
Last updated
2023-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Eosinophilic granulomatous polyangitis

Interventions

Observation group:No

Sponsors

Guangzhou Medical University affiliated with the first hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: i. With EGPA as primary diagnosis from 2015.1.1 to 2019.12.31 (International Classification of Diseases 10th edition / ICD-10 code: M30.1 or diagnosed as "eosinophilic granulomatosis with polyangiitis" or "Churg-Strauss synthesis" or EGPA or CSS abbreviation), and met the ACR or MIRRA diagnosis criteria (see appendix 2); ii. =18 years of age at index date; iii. Had at least one EGPA-related visit within one year after index date.

Exclusion criteria

Exclusion criteria: Exclude patients diagnosed with any malignant tumor during the study period.

Design outcomes

Primary

MeasureTime frame
Demographics;Clinical features;Clinical outcomes;treatment mode;Quantifying all causes;Use of medical resources;Direct medical expenses;—

Countries

China

Contacts

Public ContactQingling Zhang

Guangzhou Medical University affiliated with the first hospital

zqling68@hotmail.com+86 136 5167 8551

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026